8.18 USD
+0.28 (+3.54%)
AT CLOSE (11:59 AM EDT)
Adlai Nortye Ltd. American Depositary Shares (ANL)
NASDAQ: ANL • USD
8.18
+0.36 (+4.34%)
POST MARKET (AS OF 04:17 PM EDT)
Market: OPEN
Open?$7.75
High?$9.00
Low?$7.66
Prev. Close?$7.90
Volume?453.4K
Avg. Volume?N/A
VWAP?$8.55
Bid / Ask
Bid?$7.85 × 499.1K
Ask?$8.91 × 200
Spread?$1.06
Midpoint?$8.38
Valuation & Ratios
Market Cap?464.1M
Shares Out?31.2M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.